| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |